The China Mail - US cancels $590 million contract with Moderna for bird flu shot

USD -
AED 3.672499
AFN 62.999947
ALL 82.780483
AMD 367.570226
ANG 1.790403
AOA 917.00032
ARS 1477.474597
AUD 1.450263
AWG 1.80125
AZN 1.702517
BAM 1.717384
BBD 2.017035
BDT 123.179593
BGN 1.69088
BHD 0.377582
BIF 2974.21533
BMD 1
BND 1.295752
BOB 6.92023
BRL 5.171697
BSD 1.001497
BTN 93.997348
BWP 13.61
BYN 2.904549
BYR 19600
BZD 2.014138
CAD 1.418785
CDF 2267.4985
CHF 0.809299
CLF 0.023439
CLP 922.489575
CNY 6.79815
CNH 6.798645
COP 3444.5
CRC 454.679165
CUC 1
CUP 26.5
CVE 96.82263
CZK 21.285025
DJF 178.336846
DKK 6.559325
DOP 58.84135
DZD 133.367274
EGP 49.417703
ERN 15
ETB 161.458114
EUR 0.877603
FJD 2.24725
FKP 0.757857
GBP 0.75685
GEL 2.644988
GGP 0.757857
GHS 11.291463
GIP 0.757857
GMD 72.999684
GNF 8774.795185
GTQ 7.640297
GYD 209.58444
HKD 7.84301
HNL 26.79575
HRK 6.6128
HTG 130.881249
HUF 310.411495
IDR 17852
ILS 3.000205
IMP 0.757857
INR 94.326096
IQD 1311.878471
IRR 1375250.000078
ISK 126.389949
JEP 0.757857
JMD 157.727432
JOD 0.709008
JPY 161.799502
KES 129.497551
KGS 87.450293
KHR 4019.685748
KMF 434.000009
KPW 900.00035
KRW 1539.465014
KWD 0.309697
KYD 0.834541
KZT 485.902198
LAK 21981.331718
LBP 89681.682473
LKR 336.626187
LRD 182.415286
LSL 16.461632
LTL 2.95274
LVL 0.60489
LYD 6.428697
MAD 9.390561
MDL 17.755943
MGA 4236.056533
MKD 54.135596
MMK 2099.649649
MNT 3579.92745
MOP 8.089654
MRU 39.96751
MUR 47.240027
MVR 15.450346
MWK 1736.57243
MXN 17.487705
MYR 4.063203
MZN 63.896986
NAD 16.461632
NGN 1380.049737
NIO 36.853613
NOK 9.92633
NPR 150.396242
NZD 1.769425
OMR 0.3845
PAB 1.001462
PEN 3.414908
PGK 4.394842
PHP 61.208979
PKR 278.710567
PLN 3.76117
PYG 6112.57464
QAR 3.650397
RON 4.598018
RSD 102.986999
RUB 78.697301
RWF 1466.637981
SAR 3.760889
SBD 8.051953
SCR 14.06555
SDG 599.999936
SEK 9.7223
SGD 1.29363
SHP 0.746601
SLE 24.801218
SLL 20969.503664
SOS 572.356867
SRD 37.482964
STD 20697.981008
STN 21.513213
SVC 8.762502
SYP 110.532098
SZL 16.452478
THB 33.315503
TJS 9.268372
TMT 3.5
TND 2.968209
TOP 2.40776
TRY 46.641597
TTD 6.806108
TWD 31.892503
TZS 2627.508028
UAH 44.952516
UGX 3675.718394
UYU 40.199152
UZS 12029.065045
VES 620.752985
VND 26287.5
VUV 119.179282
WST 2.780883
XAF 576.00973
XAG 0.017017
XAU 0.000246
XCD 2.70255
XCG 1.804843
XDR 0.716371
XOF 576.007201
XPF 104.721512
YER 238.624975
ZAR 16.44495
ZMK 9001.20232
ZMW 18.040042
ZWL 321.999592
  • CMSC

    -0.1160

    21.93

    -0.53%

  • CMSD

    -0.1600

    21.77

    -0.73%

  • GSK

    0.6100

    52.5

    +1.16%

  • BCC

    1.2600

    81.02

    +1.56%

  • NGG

    -0.4100

    83.01

    -0.49%

  • RBGPF

    3.7000

    65

    +5.69%

  • BCE

    -0.2800

    22.92

    -1.22%

  • RIO

    -1.3700

    93.74

    -1.46%

  • JRI

    0.2100

    12.79

    +1.64%

  • BTI

    0.2800

    62.76

    +0.45%

  • RELX

    0.4200

    31.34

    +1.34%

  • VOD

    0.0300

    13.89

    +0.22%

  • RYCEF

    0.3900

    18.39

    +2.12%

  • AZN

    2.7300

    188.41

    +1.45%

  • BP

    -0.5900

    37.13

    -1.59%

US cancels $590 million contract with Moderna for bird flu shot
US cancels $590 million contract with Moderna for bird flu shot / Photo: © AFP/File

US cancels $590 million contract with Moderna for bird flu shot

US President Donald Trump's administration on Wednesday canceled a $590 million contract with Moderna to develop an avian flu vaccine, the US biotech company said.

Text size:

It marked the latest move against vaccines by Health Secretary Robert F. Kennedy Jr, who has spent decades promoting misinformation about immunization.

The contract, announced on January 17 -- three days before Trump took office -- was for an mRNA vaccine targeting the H5N1 influenza strain, which has been circulating in birds and cattle.

Experts have warned the virus could jump to humans and spark a pandemic.

American pharmaceutical and biotechnology company Moderna disclosed the news as it announced positive results from an early stage clinical trial of 300 people designed to test safety and immune response.

"While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis of the Phase 1/2 study of our H5 avian flu vaccine and we will explore alternative paths forward for the program," said CEO Stephane Bancel in a statement.

"These clinical data in pandemic influenza underscore the critical role mRNA technology has played as a countermeasure to emerging health threats."

The statement added Moderna would "explore alternatives" for funding the development and manufacturing of the vaccine.

Dr. Ashish Jha, a public health expert who served as former president Joe Biden's Covid-19 response coordinator, reacted with dismay.

"The attack on mRNA vaccines is beyond absurd," he posted on X. "It was President Trump's Operation Warp Speed that gave us mRNA vaccines."

P.Ho--ThChM